×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6: Block Chain
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management
Novo Nordisk, United Kingdom
To share the voice of core stakeholders and users of blockchain in drug development to discuss challenges, risks and benefits.
Speaker(s)
Regulator View
Representative Invited
FDA
The Patient Advocate Perspective
Jeanne Barnett
CysticFibrosis.com, United States
Pathfinder for Patients and Caregivers, Teacher, CEO/Founder
Heather Flannery
Equideum Health, United States
Founder and Chief Executive Officer
Have an account?